Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Postoperative Complications 1

Interventions

pembrolizumab 563 Specimen Handling 493 Carboplatin 451 Magnetic Resonance Spectroscopy 444 Cyclophosphamide 418 Cisplatin 405 Radiotherapy 353 Bevacizumab 314 Gemcitabine 313 Paclitaxel 298 Biopsy 292 Drug Therapy 284 Blood Specimen Collection 248 Capecitabine 246 Oxaliplatin 241 fludarabine 239 Nivolumab 234 venetoclax 221 Injections 213 Docetaxel 211 Fluorouracil 206 Dexamethasone 188 Radiosurgery 182 Standard of Care 159 Rituximab 159 Pemetrexed 156 Surgical Procedures, Operative 148 atezolizumab 146 durvalumab 145 Leucovorin 140

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Polyglactin 910 × Clear all

NCT07313839 2026-01-02

BI-SURE

Azienda Ospedaliero-Universitaria di Parma

Phase NA Recruiting

Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡